Courtesy Medpage Today More events Othmer Library Tour Curious about the other half of the Science History Institute
For liver health, a Phase 2a trial in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as NAFLD) showed extraordinary results
Many people successfully maintain their weight loss after stopping GLP-1 medications, especially when they: Stay active Eat enough protein Continue healthy routines Monitor weight regularly Address emotional eating Focus on long-term consistency However, maintenance usually requires ongoing effort
While some studies suggest a possible correlation between GLP-1 RAs and intestinal obstruction, others report no significant association, with discrepancies likely due to variations in study demographics, methodologies, and GLP-1 RA formulations
Advance according to symptoms and medical advice